[128] By contrast, other DAT inhibitors for instance bupropion have not been observed to exhibit this effect.[129] These observations have prompted the hypothesis that methylphenidate may possibly work as a "DAT inverse agonist" or "adverse allosteric modifier from the DAT" by reversing the route in the dopamine efflux by the DAT at increased dosag